Discovery of novel phenaleno isoquinolinium-based fluorescence imaging agents for sentinel lymph node mapping

Discovery and Feasibility Study of Medical Fluorophore 33 as a Novel Theranostic Agent

Fluorescent dyes have garnered significant attention as theranostic platforms owing to their inherent characteristics. In this study, we present the discovery of Medical Fluorophore 33 (MF33), a novel and potent theranostic agent with a phenaleno-isoquinolinium salt structure that can serve as a cancer therapeutic strategy. The synthesis of MF33 is readily achievable through a simple Rh(III)-catalyzed reaction. Moreover, MF33 displayed strong fluorescence signals, excellent microsomal stability, and high biocompatibility in vivo. It induces significant apoptosis in cancer cells via the p53/p21/caspase-3 signaling pathway, leading to selective cytotoxicity in various cancer cells. In vivo fluorescence imaging with MF33 enabled the visualization of sentinel lymph nodes in living mice. Notably, repeated intraperitoneal administration of MF33 resulted in antitumor activity in mice with colorectal cancer. Collectively, our findings suggest that phenaleno-isoquinolinium salt-based MF33 is a viable theranostic agent for biomedical imaging and cancer treatment.

Tandem C-H Annulation Reaction of Benzaldehydes and Aminobenzoic Acids with Two Equivalents of Alkyne toward Isocoumarin-Conjugated Isoquinolinium Salts: A Family of Organic Luminophores

A novel rhodium-catalyzed tandem C-H annulation of commercially available benzaldehydes and aminobenzoic acids with 2 equiv of alkyne is reported for the construction of isocoumarin-conjugated isoquinolinium salts that demonstrate diverse outstanding photoactivity. Depending on the substituents in the isoquinolinium moiety, they display either highly efficient fluorescence (up to 99% of quantum yield) or strong fluorescence quenching, which is provided by the transfer of the HOMO from the isoquinolinium to the isocoumarin moiety. Importantly, the functional groups in the benzaldehyde coupling partner also strongly affect the reaction selectivity, shifting the pathway to the formation of the photoinactive isocoumarin-substituted indenone imines and indenyl amines. Selective formation of the latter can be achieved by using a reduced amount of the oxidizing additive.

Facile construction of highly luminescent and biocompatible gold nanoclusters by shell rigidification for two-photon pH-edited cytoplasmic and in vivo imaging

Gold nanoclusters (AuNCs), as a novel fluorescent material, have been extensively explored and developed for bioimaging because of their attractive advantages such as ultrasmall size, low toxicity and exceptional two-photon excitation properties. However, it still remains a challenge to produce water-soluble, biocompatible and ultrabright AuNCs. Herein, we report on a novel one-pot synthesis of highly luminescent and biocompatible AuNCs by using polyvinyl pyrrolidone (PVP), a water-soluble polymer, to rigidify the primary stabilizing layer (shell) that is composed of 6-aza-2-thiothymine (ATT) ligands bound to the particle. Such shell-rigidification resulted in a significant enhancement of the fluorescence efficiency, reaching a quantum yield of 39% under the best conditions, about 35-fold increase from the intrinsically weak fluorescence of the AuNCs stabilized by only ATT. The fluorescence enhancement mechanism was systematically characterized, and the results indicate that PVP coating rigidifies the ATT ligand shell through steric hindrance and reduces the nonradiative relaxation of the excited states. The biocompatible PVP-AuNCs were further examined for two-photon cellular and sentinel lymph node (SLN) bioimaging, and we observed pH-dependent cytoplasmic images and intense green fluorescence in SLN and lymphatic vessels.